Mutational analysis of PRKAR1A and Gsα in sporadic adrenocortical tumors

Experimental and Clinical Endocrinology and Diabetes

Volumn 113, Issue 5, 2005, Pages 248-251

  Libe R ^a   Mantovani, G ^a   Bondioni, S ^a   Lania, A G ^a   Pedroni, C ^a   Beck Peccoz, P ^a   Spada, Anna ^a,b  

^a UNIVERSITY OF MILAN   (Italy)

^b FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

Adrenocortical tumors; Gs ; PKAR1A

Indexed keywords

CORTICOTROPIN; CYCLIC AMP DEPENDENT PROTEIN KINASE; PROTEIN SUBUNIT;

ADRENAL CORTEX ADENOMA; ADRENAL CORTEX TUMOR; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CUSHING SYNDROME; FEMALE; GENE MUTATION; GENE SEQUENCE; GENETIC CODE; GSP ONCOGENE; HETEROZYGOSITY LOSS; HUMAN; MALE; MUTATIONAL ANALYSIS; NUCLEOTIDE SEQUENCE; ONCOGENE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ADRENAL CORTEX NEOPLASMS; ADULT; AGED; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DNA MUTATIONAL ANALYSIS; FEMALE; GTP-BINDING PROTEIN ALPHA SUBUNITS, GS; HUMANS; LOSS OF HETEROZYGOSITY; MALE; MIDDLE AGED; MUTATION; POLYMERASE CHAIN REACTION; PROTEINS; SEQUENCE ANALYSIS, DNA;

EID: 20944446247     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-837651     Document Type: Article

References (20)

1. Ballare E, Mantovani S, Lania A, Di Blasio AM, Vallar L, Spada A. Activating mutations of the Gs alpha gene are associated with low levels of Gs alpha protein in growth hormone-secreting tumors. J Clin Endocrinol Metab 1998; 83: 4386-4390.
2. Bertherat J, Groussin L, Sandrini F, Matyakhina L, Bei T, Stergiopoulos S, Papageorgioo T, Bourdeau I, Kirschner LS, Vincent-Dejean C, Perlemoine K, Gicquel C, Bertagna X, Stratakis CA. Molecular and functional analysis of PRKAR1A and its locus (17q22-24) in sporadic adrenocortical tumors: 17 q losses, somatic mutations, and protein kinase A expression and activity. Canc Res 2003; 63: 5308-5319
3. Casey M, Vaughan CJ, He J, Hatcher CJ, Winter JM, Weremowicz S, Montgomery K, Kucherlapati R, Morton CC, Basson CT. Mutations in the protein kinase A R1 alpha regulatory subunit cause familial myxomas and Carney complex. J Clin Invest 2000; 106: R31-R38
4. Fragoso MC, Domenice S, Latronico AC, Martin RM, Pereira MA, Zerbini MC, Lucon AM, Mendonca BB: Cushing's syndrome secondary to adrenocorticotropin- independent macronodular adrenocortical hyperplasia due to activating mutations of GNAS1 gene. J Clin Endocrinol Metab 2003; 885: 2147-2151
5. Kaltsas GA, Kola B, Borboli N, Morris DG, Gueorguiev M, Swords FM, Czirjak S, Kirschner LS, Stratakis CA, Korbonits M, Grossman AB. Sequence analysis of the PRKAR1A gene in sporadic somatotroph and other pituitary tumours. Clin Endocrinol 2002; 57: 443-448
6. Kirschner LS, Carney JA, Pack SD, Taymans SE, Giatzakis C, Cho YS, Cho-Chung YS, Stratakis CA. Mutations of the gene encoding the protein kinase A type I-alpha regulatory subunit in patients with the Carney complex. Nat Genet 2000a; 26: 89-92
7. Kirschner LS, Sandrini F, Monbo J, Lin JP, Carney JA, Stratakis CA. Genetic heterogeneity and spectrum of mutations of the PRKAR1A gene in patients with the Carney complex. Hum Mol Genet 2000b; 9: 3037-3046
8. Kobayashi H, Usui T, Fukata J, Yoshimasa T, Oki Y, Nakao K. Mutation analysis of Gs alpha, adrenocorticotropin receptor and p53 genes in patients with adrenocortical neoplasms: including a case of Gs alpha mutation. Endocr J 2000; 47: 461-466
9. Lieberman SA, Eccleshall TR, Feldman D. ACTH-independent massive bilateral adrenal disease (AIMBAD): a subtype of Cushing's syndrome. Eur J Endocrinol 1994; 131: 67-73
10. Lionel G, Jullian E, Perlemoine K, Louvel A, Leheup B, Luton JP, Bertagna X, Bertherat J. Mutations of the PRKAR1A gene in Cushing's sindrome due to sporadic primary pigmented nodular adrenocortical disease. J Clin Endocrinol Metab 2002; 87: 4324-4329
11. Mantovani G, Romoli R, Weber G, Brunelli V, De Menis E, Beccio S, Beck-Peccoz P, Spada A. Mutational analysis of GNAS1 in patients with pseudohypoparathyroidism: identification of two novel mutations. J Clin Endocrinol Metab 2000; 85: 4243-4248
12. Mantovani G, Ballare E, Giammona E, Beck-Peccoz P, Spada A. The Gsα gene: predominant maternal origin of transcription in human thyroid gland and gonads. J Clin Endocrinol Metab 2002; 87: 4736-4740
13. Sandrini F, Kirschner LS, Bei T, Farmakidis C, Yasufuku-Takano J, Takano K, Prezant TR, Marx SJ, Farrel WE, Clayton RN, Groussin L, Bertherat J, Stratakis CA. PRKAR1A, one of the Carney complex genes, and its locus (17q22-24) are rarely altered in pituitary tumours outside the Carney complex. J Med Genet 2002; 39: e78
14. Sandrini F, Stratakis CA. Clinical and molecular genetics of Carney complex. Mol Genet Metab 2003; 78: 83-92
15. Sarlis NJ, Chrousos JP, Doppman JL, Carney JA, Stratakis CA. Primary pigmented nodular adrenocortical disease: reevaluation of a patient with Carney complex 27 years after unilateral adrenalectomy. J Clin Endocrinol Metab 1997; 82: 1274-1278
16. Stratakis CA, Sarlis N, Kirschner LS, Carney JA, Doppman JL, Nieman LK, Chrousos GP, Papanicolaou DA. Paradoxical response to dexamethasone in the diagnosis of primari pigmented nodular adrenocortical disease. Ann Intern Med 1999; 131: 585-591
17. Stratakis CA, Kirschner LS, Carney JA. Clinical and molecular features of the Carney complex: diagnostic criteria and recommendations for patient evaluation. J Clin Endocrinol Metab 2001; 86: 4041-4046
18. Travis WD, Tsokos M, Doppman JL, Nieman L, Chrousos GP, Cutler Jr GB, Loriaux DL, Norton JA. Primary pigmented nodular adrenocortical disease. A light and electron microscopic study of eight cases. Am J Surg Pathol 1989; 13: 921-930
19. Weinstein LS, Shenker A, Gejman P, Marino MJ, Friedman E, Spiegel AM. Activating mutations of the stimulatory G protein in the McCune-Albright syndrome. New Engl J Med 1991; 325: 1688-1695
20. Yamasaki H, Mizusawa N, Nagahiro S, Yamada S, Sano T, Itakura M, Yoshimoto K. GH-secreting pituitary adenomas infrequently contain inactivating mutations of PRKAR1A and LOH of 17q23-24. Clin Endocrinol 2003; 58: 464-470